S. Schulman

Chest · 2005–2022

A researcher in the Science corpus: 16 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts S. Schulman overall

1. Gregory Y. H. Lip
2. S. Konstantinides
3. G. Agnelli
4. M. Lassen
5. G. Raskob
6. A. Gallus

Papers from S. Schulman's perspective

Ordered by how strongly the researchers S. Schulman trusts endorse each paper. Same corpus, a different order for every researcher.

1. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. (Archives of Internal Medicine)
2. Fibrinolysis for patients with intermediate-risk pulmonary embolism. (New England Journal of Medicine)
3. Oral apixaban for the treatment of acute venous thromboembolism. (New England Journal of Medicine)
4. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. (Journal of Clinical Epidemiology)
5. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (New England Journal of Medicine)
6. Emergency hospitalizations for adverse drug events in older Americans. (New England Journal of Medicine)
7. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. (New England Journal of Medicine)
8. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. (Archives of Internal Medicine)
9. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. (The Lancet)
10. GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)

Their papers

• 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. (2022) — 1,049 citations
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) — 2,222 citations
• American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. (2020) — 1,119 citations
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation (2015) — 952 citations
• Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH (2015) — 1,230 citations
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis (2014) — 912 citations
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. (2014) — 801 citations
• Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. (2013) — 930 citations
• Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 2,418 citations
• Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 2,080 citations
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 1,049 citations
• Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 995 citations
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients (2010) — 2,386 citations
• Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (2009) — 2,549 citations
• Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) — 773 citations
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients (2005) — 4,651 citations